In this free webinar, gain practical insights on early access programs (EAPs) in European commercialization. Attendees will learn to navigate challenges and utilize EAPs as a bridge to successful commercialization. The featured speaker will discuss building a strong strategy that includes early stakeholder engagement and transitional thinking
TORONTO, March 11, 2024 /PRNewswire-PRWeb/ -- Early access programs (EAPs) act as a bridge to successful commercialization. This webinar will focus on the ways EAPs engage stakeholders and foster advocacy among patient organizations, physicians and key opinion leaders. The session will help gain insights into the best time in clinical development to prepare for launch and the importance of adopting transitional thinking from clinical development to commercial launch.
During this webinar, the attendees will get to explore the role of EAPs in gathering real-world data and the potential to generate revenue within certain markets. The featured speaker will share insights into EAPs and their impact on EU commercialization. Also, the session will help attendees navigate the real challenges faced in weaving EAPs into commercial strategies, as well as understand the complexities around managing cost, small patient populations in rare diseases, resource allocation and navigating the intricacies of European regulation.
The attendees will also gain practical considerations for crafting a strong EAP strategy and understand the importance of:
1. Starting early
2. Starting with the end in mind
3. Engaging with key stakeholders early
During the webinar, the attendees can directly engage with the experts, ask their burning questions and receive personalized insights to navigate the challenges they are facing in implementing EAPs in their European commercialization strategy.
Register now to gain insights into how EAPs act as a bridge to successful commercialization in the EU market.
Join Heather Masters, VP Global Pricing & Market Access, WEP Clinical, for the live webinar on Thursday, March 28, 2024, at 11am EDT (4pm CET/EU-Central).
For more information, or to register for this event, visit Early Access Programs: Adding Value to EU Commercialization Strategy.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], http://xtalks.com
SOURCE Xtalks
Share this article